# ExaEarn Phase 15B Completion Report

## A. Changes Implemented

- Institutional application lifecycle.
- Maker-checker admin activation.
- Institutional master accounts.
- Subaccounts mapped to canonical ledger accounts.
- Institutional team RBAC and subaccount permissions.
- Ledger-backed internal transfers with idempotency.
- VIP tier definitions and tier history.
- Institution-specific fee profiles.
- Phase 14 API key institutional scope.
- Web app Institutional & VIP workspace.
- Website `/institutional` and `/institutional/apply` surfaces.
- Admin Institutional & VIP module.

## B. Canonical Ledger

Institutional balances are authoritative only through ledger accounts and `BalanceProjectionService`.

## C. Security

Sanctum, admin middleware, maker-checker, idempotency, scoped permissions and audit events are used for all implemented workflows.

## D. Tests

Focused Phase 15B tests cover application lifecycle, maker-checker activation, subaccounts, ledger-funded transfer, idempotency, cross-institution blocking, API subaccount spoofing, VIP fee calculation and reporting.

Verified locally:

- Phase 15B focused backend: `1 passed / 0 failed / 52 assertions`
- Phase 15A focused backend regression: `2 passed / 0 failed / 54 assertions`
- Phase 14 developer platform regression: `13 passed / 0 failed / 1102 assertions`
- Full backend suite: `372 passed / 0 failed / 1 skipped / 2726 assertions`
- Web app typecheck: `PASS`
- Website typecheck: `PASS`
- Admin typecheck: `PASS`
- Web app production build: `PASS`
- Website production build: `PASS`
- Admin production build: `PASS`
- Institutional realtime replay: `PASS`

## E. Remaining Risks

- Product-specific Spot/Futures/Margin controllers should further consume institutional request scope for institution-native order entry.
- Real KYB document storage and external compliance review remain operational/compliance integrations.
- Market-maker and OTC production launch require operations policy and surveillance configuration.

## F. Readiness

Phase 15B software is ready for controlled continuation. External KYB/compliance vendor integration, institutional operations staffing, contractual VIP approvals, market-maker agreements and OTC operations policy remain non-code production-launch gates.
